Furthermore, WT1 also exhibits oncogenic activity, and its overexpression has been well demonstrated in ovarian cancer; thus, WT1 immunohistochemical detection is considered as a diagnostic marker of ovarian cancer (Figure 2B) (8). Here, WT1 is linked to ovarian cancer.